MedTrace Logo

Droplet-BC Screening Test for the Detection of Breast Cancer, the DROPLET-BC Study

NCT04671498 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2022-06-21

No results posted yet for this study

Summary

This study investigates if a new type of test called Droplet-BC screening test can classify breast cancer patients from non-cancer volunteers by circulating small-noncoding RNA in the blood with a statistical validity. This study also investigates if this test can classify the subgroup of breast cancer patients with a variety of conditions. Information from this study may provide a new method of breast cancer screening/diagnosis

Conditions

  • Breast Carcinoma

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of blood sample

PROCEDURE

Droplet-BC Test

Undergo Droplet-BC Test

OTHER

Electronic Health Record Review

Medical records are reviewed

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Preferred Medicine, Inc

    lead INDUSTRY

Principal Investigators

  • Naoto T Ueno · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-03
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04671498 on ClinicalTrials.gov